Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • mrfox
    Senior Member
    • Aug 2010
    • 103

    #1

    too many indels output by varscan2

    Hi all,

    I used varscan2.3.2 to study groups of normal/tumor matched data sets. I used java -jar Varscan2.3.2 somatic [normal pileup] [tumor pileup]. It outputs about 9,000 indels, of which most of them are reported as Germline and about one hundred of them were LOH or Somatic.

    This is my first exome-sequencing project. Does any one has an idea what happened to predict so many indels? BTW, I used bwa to map the reads and duplicates were removed before SNV call.

    Thank you.
  • dkoboldt
    Member
    • Mar 2009
    • 62

    #2
    Hello,

    I'm not sure what you expected to get, but those numbers (~9,000 called, of which 99% were germline/inherited, and 1% were somatic or LOH) are fairly typical for tumor-normal comparisons. Note that both "Germline" and "LOH" variants are present in the normal, but the latter became homozygous in the tumor due to loss of one allele.

    Note that you can use the processSomatic command of VarScan to parse your output and break it down according to somatic status (germline, LOH, somatic) and confidence (high or low).

    Comment

    • dkoboldt
      Member
      • Mar 2009
      • 62

      #3
      SeqAnswers is OK because we do monitor it, however, you might hear back faster from us if you post to the VarScan Help Forum.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        Today, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 05:39 AM
      0 responses
      10 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, Yesterday, 09:56 AM
      0 responses
      12 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-09-2026, 11:14 AM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 09-29-2026, 09:51 AM
      0 responses
      77 views
      0 reactions
      Last Post SEQadmin2  
      Working...